Wednesday, February 5, 2014

A Cure for Breast Cancer?

News Brief by Sam Kessel

An early stage study conducted at the Henry Ford Hospital has shown that melatonin, a hormone that is released naturally in the body to regulate sleep, could potentially be used to treat triple negative breast cancer. The researchers observed that mice treated with melatonin had tumors that significantly decreased in size, while the untreated mice suffered substantial tumor growth in the 21-day study. The reason melatonin seems to work is because it acts as an antioxidant and prevents tumors from growing a blood supply from the body. These promising results suggest that more basic research needs to be done in order to figure out how melatonin impacts blood vessel growth in various types of cancers before clinical testing on humans can start.

Henry Ford Health System. (2014, January 28). Melatonin shows potential to slow tumor growth in certain breast cancers. ScienceDaily. Retrieved February 4, 2014 from

blog comments powered by Disqus

TuftScope: The Interdisciplinary Journal of Health, Ethics, and Policy

TuftScope is a student journal published biannually in conjunction with Tufts University since 2001. Funding is provided by the Tufts Community Union Senate. The opinions expressed on this weblog are solely those of the authors. The staff reserves the right to edit blog postings for clarity and to remove nonfunctional links.

  © Free Blogger Templates Autumn Leaves by 2008

Back to TOP